Puma Biotechnology Inc. (PBYI)
NASDAQ · Healthcare
Puma Biotechnology Inc. Gross Profit 2017–2025
Puma Biotechnology Inc. annual/quarterly gross profit history and growth rate from 2017 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Puma Biotechnology Inc. gross profit for the quarter ending March 31, 2026 was 34.4 M, a 2.99% decrease year-over-year.
- Puma Biotechnology Inc. gross profit for the twelve months ending March 31, 2026 was 152.3 M, a 7.00% decrease year-over-year.
- Puma Biotechnology Inc. annual gross profit for 2025 was 170.2 M, a 2.50% increase from 2024.
- Puma Biotechnology Inc. annual gross profit for 2024 was 166.1 M, a 3.98% decrease from 2023.
- Puma Biotechnology Inc. annual gross profit for 2023 was 173.0 M, a 0.01% increase from 2022.
- Puma Biotechnology Inc. annual gross profit for 2022 was 172.9 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Puma Biotechnology Inc. Gross Profit — FAQ
Puma Biotechnology Inc. (PBYI) gross profit over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Puma Biotechnology Inc.'s gross profit?
Puma Biotechnology Inc. (PBYI) reported gross profit of $170M for fiscal 2025.
Where can I see PBYI's gross profit history?
The chart and table above show Puma Biotechnology Inc.'s gross profit by year and by quarter, including the growth rate.